title: MIF Gene Polymorphism rs755622 Is Associated With Coronary Artery Disease and Severity of Coronary Lesions in a Chinese Kazakh Population: A Case-Control Study.
abstract: Inflammation plays an important role in the pathogenesis of atherosclerosis. Recent studies indicate that macrophage migration inhibitory factor (MIF) is a potent proinflammatory cytokine which mediates the inflammatory process during atherosclerosis. The polymorphism of MIF gene (rs755622 [-173G/C], rs1007888, and rs2096525) were genotyped by TaqMan single nucleotide polymorphism (SNP) genotyping assay in 320 patients with coronary artery disease (CAD) and 603 controls in a Chinese Kazakh population. Coronary angiography was performed on all CAD patients and Gensini score was used to assess the severity of coronary artery lesions. The frequency of the CC genotype and C allele of rs755622 were significantly higher in CAD patients than that in control subjects (8.4% vs. 5.1%, P < 0.001, 30.3% vs. 22.1%, P < 0.001, respectively). Multivariate logistic regression analysis showed that individuals with CC genotype or C allele had a higher risk for CAD (CC genotype vs. GG genotype, OR = 2.224, 95% CI, 1.239-3.992, P = 0.007, and C allele vs. G allele, OR = 1.473, 95% CI, 1.156-1.876, P = 0.002, respectively). Moreover, CAD patients with rs755622 C allele (CC + CG genotype) have higher levels of Gensini score when compared to C allele noncarriers (32.74 ± 26.66 vs. 21.44 ± 19.40, P < 0.001, adjusted). Our results suggested that the CC genotype and C allele of MIF rs755622 SNP may be a genetic marker for the risk of CAD and potentially predict the severity of CAD in Chinese Kazakh population.
authors.affiliation: From the Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China (J-YL, X-ML, YZ, QZ, Y-TM, Y-NY); Xinjiang Key Laboratory of Cardiovascular Disease Research, Urumqi, Xinjiang, China (J-YL, X-ML, FL, B-DC, Y-TM, X-MG, Y-NY); Department of Cadres Health, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (RX); Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China (X-MG); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (X-MG); and Department of Surgery, Central Clinical School, Monash University, Melbourne, Victoria, Australia (X-MG).
authors.forename: Jun-Yi
authors.initials: JY
authors.lastname: Luo
authors.forename: Rui
authors.initials: R
authors.lastname: Xu
authors.forename: Xiao-Mei
authors.initials: XM
authors.lastname: Li
authors.forename: Yun
authors.initials: Y
authors.lastname: Zhou
authors.forename: Qian
authors.initials: Q
authors.lastname: Zhao
authors.forename: Fen
authors.initials: F
authors.lastname: Liu
authors.forename: Bang-Dang
authors.initials: BD
authors.lastname: Chen
authors.forename: Yi-Tong
authors.initials: YT
authors.lastname: Ma
authors.forename: Xiao-Ming
authors.initials: XM
authors.lastname: Gao
authors.forename: Yi-Ning
authors.initials: YN
authors.lastname: Yang
mesh_terms: D000368:Aged; D044466:Asian People / Q000235:genetics*; D015415:Biomarkers; D016022:Case-Control Studies; D002681:China; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging* / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D019746:Intramolecular Oxidoreductases / Q000235:genetics*; D008263:Macrophage Migration-Inhibitory Factors / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D008263:Macrophage Migration-Inhibitory Factors; D019746:Intramolecular Oxidoreductases; C515598:MIF protein, human
references.citation: Arteriosclerosis. 1989 Sep-Oct;9(5):567-78
references.pmid: 2675808
references.citation: J Mol Med (Berl). 2008 Jul;86(7):761-70
references.pmid: 18385967
references.citation: Invest Ophthalmol Vis Sci. 2013 Nov 21;54(12):7734-8
references.pmid: 24194192
references.citation: Cytokine. 2013 Mar;61(3):759-65
references.pmid: 23402792
references.citation: Clin Chim Acta. 2009 Jan;399(1-2):1-7
references.pmid: 18838066
references.citation: World J Gastroenterol. 2013 Oct 21;19(39):6656-64
references.pmid: 24151396
references.citation: Cytokine. 2008 Jan;41(1):44-7
references.pmid: 18054247
references.citation: J Am Coll Cardiol. 2003 Jan 1;41(1):159-68
references.pmid: 12570960
references.citation: Circulation. 2002 Mar 5;105(9):1135-43
references.pmid: 11877368
references.citation: Control Clin Trials. 1998 Dec;19(6):589-601
references.pmid: 9875838
references.citation: Thromb Haemost. 2008 May;99(5):944-50
references.pmid: 18449426
references.citation: J Am Heart Assoc. 2013 Oct 04;2(5):e000226
references.pmid: 24096574
references.citation: Circulation. 2004 Jan 27;109(3):380-5
references.pmid: 14691040
references.citation: Atherosclerosis. 2008 Oct;200(2):380-8
references.pmid: 18242614
references.citation: Genet Test Mol Biomarkers. 2014 Jun;18(6):430-8
references.pmid: 24818816
references.citation: J Breast Cancer. 2013 Mar;16(1):50-4
references.pmid: 23593081
references.citation: Clin Res Cardiol. 2013 Jul;102(7):495-503
references.pmid: 23519584
references.citation: PLoS One. 2013 Nov 07;8(11):e80185
references.pmid: 24244645
references.citation: Am J Cardiovasc Drugs. 2015 Feb;15(1):1-11
references.pmid: 25369900
references.citation: Clin Chim Acta. 2009 Apr;402(1-2):199-202
references.pmid: 19167373
references.citation: J Immunol Res. 2014;2014:704854
references.pmid: 25105152
references.citation: Atherosclerosis. 2006 Jan;184(1):28-38
references.pmid: 15921687
references.citation: Arthritis Rheum. 2002 Sep;46(9):2402-9
references.pmid: 12355488
references.citation: PLoS One. 2012;7(6):e38376
references.pmid: 22693633
references.citation: Cytokine. 2014 Oct;69(2):272-6
references.pmid: 24951298
references.citation: Ophthalmology. 2012 Dec;119(12):2514-8
references.pmid: 22939113
references.citation: Lipids Health Dis. 2014 Jan 06;13:4
references.pmid: 24393232
references.citation: Atherosclerosis. 2014 Dec;237(2):748-53
references.pmid: 25463115
references.citation: Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):72-8
references.pmid: 21733941
references.citation: Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Oct;23(5):548-50
references.pmid: 17029206
references.citation: Arthritis Res Ther. 2013;15(3):R65
references.pmid: 23721694
references.citation: Biomed Res Int. 2015;2015:315174
references.pmid: 25821795
references.citation: Diabetologia. 2008 Feb;51(2):276-84
references.pmid: 17712545
references.citation: PLoS One. 2013 Oct 01;8(10):e76206
references.pmid: 24098445
references.citation: Bioimpacts. 2014;4(3):133-9
references.pmid: 25337466
references.citation: Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Oct;36(10):912-5
references.pmid: 19102890
references.citation: Kidney Int. 1986 Nov;30(5):673-7
references.pmid: 3537459
references.citation: Hum Immunol. 2014 May;75(5):433-9
references.pmid: 24530749
references.citation: Atherosclerosis. 2010 Dec;213(2):573-8
references.pmid: 20934703
references.citation: Isr Med Assoc J. 2008 Jul;10(7):494-8
references.pmid: 18751625
references.citation: Arthritis Rheum. 2005 Oct;52(10):3020-9
references.pmid: 16200611
references.citation: Curr Pharm Des. 2009;15(18):2104-9
references.pmid: 19519441
references.citation: Circulation. 2008 Mar 25;117(12):1594-602
references.pmid: 18362243
references.citation: Trends Cardiovasc Med. 2009 Apr;19(3):76-86
references.pmid: 19679264
references.citation: Lipids Health Dis. 2013 Dec 17;12:185
references.pmid: 24341701